Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo

被引:72
作者
Eloranta, JJ [1 ]
Hurst, HC [1 ]
机构
[1] Hammersmith Hosp, Mol Oncol Unit, Canc Res United Kingdom, London W12 0NN, England
关键词
D O I
10.1074/jbc.M202780200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The members of the AP-2 family of transcription factors are developmentally regulated and have distinct yet overlapping functions in the regulation of many genes governing growth and differentiation. All AP-2 factors appear to be capable of binding very similar DNA recognition sites, and the determinants of functional specificity remain to be elucidated. AP-2 transcription factors have been shown to act both as transcriptional activators and repressors in a promoter-specific manner. Although several mediators of their activation function have been suggested, few mechanisms for the repression or down-regulation of transactivation have been described. In a two-hybrid screen for proteins interacting with AP-2 factors, we have identified the UBC9 gene that encodes the E2 (ubiquitin carrier protein)-conjugating enzyme for the small ubiquitin-like modifier, RUMO. The interaction domain resides in the C-terminal half of AP-2, which contains the conserved DNA binding and dimerization domains. We have detected sumolated forms of endogenous AP-2 in mammalian cells and have further mapped the in vivo sumolation site to conserved lysine 10. Transient transfection studies indicate that sumolation of AP-2 decreases its transcription activation potential, and we discuss the possible mechanisms for the observed suppression of AP-2 transactivation.
引用
收藏
页码:30798 / 30804
页数:7
相关论文
共 52 条
  • [1] Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator
    Bamforth, SD
    Bragança, J
    Eloranta, JJ
    Murdoch, JN
    Marques, FIR
    Kranc, KR
    Farza, H
    Henderson, DJ
    Hurst, HC
    Bhattacharya, S
    [J]. NATURE GENETICS, 2001, 29 (04) : 469 - 474
  • [2] Role of AP-2 in tumor growth and metastasis of human melanoma
    Bar-Eli, M
    [J]. CANCER AND METASTASIS REVIEWS, 1999, 18 (03) : 377 - 385
  • [3] Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1
    Bernier-Villamor, V
    Sampson, DA
    Matunis, MJ
    Lima, CD
    [J]. CELL, 2002, 108 (03) : 345 - 356
  • [4] THE DEVELOPMENTALLY-REGULATED TRANSCRIPTION FACTOR AP-2 IS INVOLVED IN C-ERBB-2 OVEREXPRESSION IN HUMAN MAMMARY-CARCINOMA
    BOSHER, JM
    WILLIAMS, T
    HURST, HC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) : 744 - 747
  • [5] Bosher JM, 1996, ONCOGENE, V13, P1701
  • [6] Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2
    Bragança, J
    Swingler, T
    Marques, FIR
    Jones, T
    Eloranta, JJ
    Hurst, HC
    Shioda, T
    Bhattacharya, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) : 8559 - 8565
  • [7] AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis
    Chazaud, C
    OuladAbdelghani, M
    Bouillet, P
    Decimo, D
    Chambon, P
    Dolle, P
    [J]. MECHANISMS OF DEVELOPMENT, 1996, 54 (01) : 83 - 94
  • [8] Ubch9 conjugates SUMO but not ubiquitin
    Desterro, JMP
    Thomson, J
    Hay, RT
    [J]. FEBS LETTERS, 1997, 417 (03) : 297 - 300
  • [9] Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1
    Desterro, JMP
    Rodriguez, MS
    Kemp, GD
    Hay, RT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (15) : 10618 - 10624
  • [10] Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation
    García, MA
    Campillos, M
    Marina, A
    Valdivieso, F
    Vázquez, J
    [J]. FEBS LETTERS, 1999, 444 (01) : 27 - 31